15432 Federal Register / Vol. 87, No. 53 / Friday, March 18, 2022 / Notices 

Review Officer, National Center for 

Injury Prevention and Control, CDC, 

4770 Buford Highway NE, Mailstop 

S106–9, Atlanta, Georgia 30341, 

Telephone (404) 639–6473, AWilkes@

cdc.gov. 

The Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Strategic Business Initiatives Unit, 

Office of the Chief Operating Officer, Centers 

for Disease Control and Prevention. 

[FR Doc. 2022–05748 Filed 3–17–22; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended, and the Determination of 

the Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, CDC, pursuant to 

Public Law 92–463. The grant 

applications and the discussions could 

disclose confidential trade secrets or 

commercial property such as patentable 

material, and personal information 

concerning individuals associated with 

the grant applications, the disclosure of 

which would constitute a clearly 

unwarranted invasion of personal 

privacy. 

Name of Committee: Disease, 

Disability, and Injury Prevention and 

Control Special Emphasis Panel; 

(SEP)—GH20–002, Malaria Operations 

Research to Improve Malaria Control 

and Reduce Morbidity and Mortality in 

Western Kenya; GH20–003, Conducting 

Public Health Research in Colombia; 

GH21–003, Advancing Public Health 

Research in Kenya; and GH22–001, 

Enhancing Capacity for Strategic and 

Applied Research Activities in Support 

of Control and Elimination of Malaria 

and Other Parasitic Diseases. 

Date: April 13, 2022. 

Time: 9:00 a.m.–2:00 p.m., EDT. 

Place: Teleconference. 

Agenda: To review and evaluate grant 

applications. 

FOR FURTHER INFORMATION CONTACT: 

Hylan Shoob, Ph.D., Scientific Review 

Officer, Center for Global Health, CDC, 

1600 Clifton Road NE, Mailstop H21–9, 

Atlanta, Georgia 30329–4027, 

Telephone: (404) 639–4796; Email: 

HShoob@cdc.gov. 

The Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Strategic Business Initiatives Unit, 

Office of the Chief Operating Officer, Centers 

for Disease Control and Prevention. 

[FR Doc. 2022–05751 Filed 3–17–22; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel; (SEP)—CE22–008, 

‘‘Using Data Linkage To Improve Our 

Understanding of Suicide/Self-Inflicted 

Injury and/or Drowning’’; Amended 

Notice of Meeting 

Notice is hereby given of a change in 

the meeting of the Disease, Disability, 

and Injury Prevention and Control 

Special Emphasis Panel (SEP)—CE22– 

008, ‘‘Using Data Linkage to Improve 

Our Understanding of Suicide/Selfinflicted Injury and/or Drowning’’, May 

24–25, 2022, 8:30 a.m., EDT–5:30 p.m., 

EDT, Videoconference, in the original 

FRN. The meeting was published in the 

Federal Register on January 14, 2022, 

Volume 87, Number 10, page/s/2440– 

2441. 

The meeting is being amended to 

change the meeting date and should 

read as follows: 

CE22–008, ‘‘Using Data Linkage to 

Improve Our Understanding of Suicide/ 

Self-inflicted Injury and/or Drowning’’, 

May 24, 2022, 1:00 p.m., EDT–5:00 p.m., 

EDT. 

The meeting is closed to the public. 

FOR FURTHER INFORMATION CONTACT: 

Mikel Walters, Ph.D., Scientific Review 

Officer, National Center for Injury 

Prevention and Control, CDC, 4770 

Buford Highway NE, Mailstop F–63, 

Atlanta, Georgia 30341, Telephone (404) 

639–0913, MWalters@cdc.gov. 

The Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Strategic Business Initiatives Unit, 

Office of the Chief Operating Officer, Centers 

for Disease Control and Prevention. 

[FR Doc. 2022–05749 Filed 3–17–22; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

[Docket No. CDC–2022–0037; NIOSH 278] 

Board of Scientific Counselors, 

National Institute for Occupational 

Safety and Health (BSC, NIOSH) 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice of meeting and request 

for comment. 

SUMMARY: In accordance with the 

Federal Advisory Committee Act, the 

CDC announces the following virtual 

meeting of the Board of Scientific 

Counselors, National Institute for 

Occupational Safety and Health (BSC, 

NIOSH). This is a virtual meeting and 

open to the public, limited only by web 

conference lines (500 web conference 

lines are available). Time will be 

available for public comment. 

DATES: The meeting will be held on 

April 20, 2022, from 10:00 a.m.–3:00 

p.m., EDT. 

Written comments must be submitted 

by April 13, 2022. 

ADDRESSES: This is a virtual meeting. 

You may submit comments, identified 

by Docket No. CDC–2022–0037; 

NIOSH–278 by mail. CDC does not 

accept comments by email. 

• Federal eRulemaking Portal: 

https://www.regulations.gov. Follow the 

instructions for submitting comments. 

• Mail: Docket number CDC–2021– 

0037; NIOSH–278, c/o Sherri Diana, 

NIOSH Docket Office, National Institute 


jspears on DSK121TN23PROD with NOTICES1